OverviewChartNewsTraderScreen

BVT Knock-Out AMGN/  DE000VD5V6F0  /

Stuttgart
2024-08-05  10:09:17 AM Chg.-0.61 Bid10:23:03 AM Ask10:23:03 AM Underlying Strike price Expiration date Option type
3.74EUR -14.02% 3.97
Bid Size: 7,000		 -
Ask Size: -		 Amgen Inc 285.86 USD 2078-12-31 Call
TeleTrader 08-01 Dow jumps 250 pts as Meta surges more than 10%
GlobeNewswire 07-01 Zenas BioPharma Appoints Orlando Oliveira as Chief Commercial Officer
GlobeNewswire 06-27 Eliem Therapeutics Announces the Closing of its Acquisition of Tenet Medicines and Concurrent $120 M...
GlobeNewswire 06-27 Coherus BioSciences Announces Divestiture of YUSIMRY (adalimumab-aqvh) in a $40 Million Upfront All ...
GlobeNewswire 06-26 COUR Pharmaceuticals Appoints Tim Walbert to its Board of Directors
GlobeNewswire 06-26 Compass Pathways appoints Lori Englebert as Chief Commercial Officer
GlobeNewswire 06-25 Arthritis Foundation Launches Carolina Hills Classic Bike Tour, Coming June 2025
TeleTrader 06-24 US closes mostly lower, as energy, banking stocks take lead
GlobeNewswire 06-20 Biotechs Race to Develop New Treatments as Global Pancreatic Cancer Market Size Expected to Reach $7...
GlobeNewswire 06-19 Jasper Therapeutics Announces Appointment of Svetlana Lucas Ph.D., to its Board of Directors
GlobeNewswire 06-18 CytomX Therapeutics to Present at the H.C. Wainwright 2nd Annual Immune Cell Engager Virtual Confere...
GlobeNewswire 06-17 CytomX Therapeutics Promotes Chris Ogden to Chief Financial Officer
GlobeNewswire 06-17 FDA Approves Phase II Clinical Trial for Ruxoprubart in ANCA Associated Vasculitis (AAV) – a Chronic...
GlobeNewswire 06-17 Solid Power Appoints Renewables Industry Veteran Linda Heller as Chief Financial Officer
GlobeNewswire 06-05 Coherus BioSciences Appoints Rita Karachun, CPA, CGMA to its Board of Directors
GlobeNewswire 05-30 Crinetics Pharmaceuticals Appoints Robert M. Cuddihy, M.D., as Senior Vice President of Medical Affa...
TeleTrader 05-28 US markets turn to losses, Dow plunges 330 points
TeleTrader 05-28 Wall Street opens mostly higher as T+1 stock trading returns
GlobeNewswire 05-28 Apogee Therapeutics Expands Board of Directors with the Appointment of Lisa Bollinger, MD
GlobeNewswire 05-27 Samsung Bioepis Announces Oral Presentation on Switching Period Results for SB16, a Proposed Biosimi...
GlobeNewswire 05-23 Coherus Presents Preliminary Results from Phase I Dose Escalation Study of its Anti-chemokine recept...
GlobeNewswire 05-22 CytomX Therapeutics to Present at the Jefferies Global Healthcare Conference
GlobeNewswire 05-22 Sandoz receives European Commission approval for Wyost® and Jubbonti®, the first and only biosimilar...
GlobeNewswire 05-21 Alvotech Reports Financial Results for First Quarter of 2024 and Provides a Business Update
GlobeNewswire 05-21 Alvotech and Dr. Reddy’s enter into collaboration for commercialization of AVT03 (denosumab), a bios...